Anti-PD-1/LAG3 bispecific antibodies
US11072658B2 · kind B2 · utility
2Cited by
17References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 31, 2019 |
| Grant date | Jul 27, 2021 |
| Priority date | — |
| Expiry date | Mar 31, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided herein are anti-PD-1/LAG3 bispecific antibodies and antigen-binding fragments. Also provided here are methods and uses of these antibodies and antigen-binding fragments in the treatment of cancer or infectious disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.